More about

Severe Asthma

News
May 15, 2022
3 min read
Save

Fixed-dose albuterol-budesonide rescue inhaler cuts severe asthma attack risk: MANDALA

Fixed-dose albuterol-budesonide rescue inhaler cuts severe asthma attack risk: MANDALA

SAN FRANCISCO — In patients with uncontrolled moderate to severe asthma, a fixed-dose combination of albuterol and budesonide used as an as-needed rescue medication lowered risk for severe asthma exacerbations compared with albuterol alone.

News
April 26, 2022
4 min read
Save

High use of short-acting beta 2 agonists may be ‘danger signal’ of more severe asthma

High use of short-acting beta 2 agonists may be ‘danger signal’ of more severe asthma

Although infrequent, high use of short-acting beta 2 agonists was associated with more severe asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

News
April 15, 2022
3 min read
Save

Severe asthma exacerbations associated with short-acting beta 2 agonist use

Severe asthma exacerbations associated with short-acting beta 2 agonist use

Increasing exposure to short-acting beta 2 agonist rescue or reliever medication appeared associated with greater risk for severe asthma exacerbations regardless of inhaled corticosteroid use, according to study results.

News
March 29, 2022
1 min read
Save

Bronchial thermoplasty for severe asthma safe, effective, durable at 5 years

Bronchial thermoplasty for severe asthma safe, effective, durable at 5 years

Patients with severe asthma experienced decreased exacerbations, hospitalizations, ED visits and corticosteroid exposure 5 years after treatment with bronchial thermoplasty, researchers reported.

News
March 23, 2022
4 min read
Save

Benralizumab achieves real-world reductions in severe asthma exacerbations, medical costs

Benralizumab achieves real-world reductions in severe asthma exacerbations, medical costs

Patients with severe asthma saw significant reductions in exacerbations, oral corticosteroid use, exacerbation-related health care resource utilization and medical costs with benralizumab, according to recent research.

News
March 07, 2022
2 min read
Save

Children with severe asthma may be more at risk for NSAID-exacerbated respiratory disease

Children with severe asthma may be more at risk for NSAID-exacerbated respiratory disease

PHOENIX — Children with severe asthma appeared more likely to experience NSAID-exacerbated respiratory disease, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

News
February 26, 2022
2 min read
Save

Tezepelumab reduces asthma exacerbations across all seasons

Tezepelumab reduces asthma exacerbations across all seasons

PHOENIX — Tezepelumab consistently reduced exacerbations in adults and adolescents with severe asthma across all seasons, according to NAVIGATOR trial results presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

News
January 20, 2022
2 min read
Save

Asthma severity tied to more severe COVID-19 outcomes

Asthma severity tied to more severe COVID-19 outcomes

In a new study, all asthma phenotypes were associated with risk for more severe COVID-19 outcomes, except for type 2 inflammation, researchers reported in the American Journal of Respiratory and Critical Care Medicine.

News
January 04, 2022
2 min read
Save

Asthma year in review: COVID-19, new drug approvals and more

Asthma year in review: COVID-19, new drug approvals and more

The Healio Editors compiled the most-read asthma news published in 2021.

News
December 20, 2021
1 min read
Save

FDA approves tezepelumab for severe asthma

FDA approves tezepelumab for severe asthma

The FDA has approved tezepelumab for add-on maintenance treatment of adults and children aged 12 years and older with severe asthma.

View more